UTAH MEDICAL PRODUCTS INC (UTMD) Gross margin 2016–2025
UTAH MEDICAL PRODUCTS INC (UTMD) gross margin by fiscal year — reported gross profit divided by reported revenue.
57.1%FY2025 · since FY2016: 60.3% → 57.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 57.1% | -1.9 pp |
| FY2024 | 59.0% | -0.8 pp |
| FY2023 | 59.8% | -1.8 pp |
| FY2022 | 61.6% | -1.4 pp |
| FY2021 | 63.0% | +2.5 pp |
| FY2020 | 60.6% | -2.3 pp |
| FY2019 | 62.8% | +0.2 pp |
| FY2018 | 62.6% | -1.1 pp |
| FY2017 | 63.7% | +3.5 pp |
| FY2016 | 60.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice